FABP4 and myocardial ischemia: In our previous studies, FABP4, which has originally been identified as intracellular lipid chaperone that mediates lipid metabolism and inflammation41, was rapidly and robustly increased in the patients with AMI in general, and in patients complicated with out of hospital cardiac arrest (OHCA) irrespective of the severity of myocardial ischemia in particular19.